コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ling induced by the chemokine ligand CXCL12 (stromal cell-derived factor 1).
2 activation of MMP-9 and enhanced release of stromal cell-derived factor 1.
3 ble of inducing emigration, one of which was stromal cell-derived factor-1.
4 JVS-100 is a DNA plasmid encoding human stromal cell-derived factor-1.
5 (VEGF), inducible nitric oxide synthase, and stromal cell-derived factor-1.
6 (MMP)9 activity and decreased expression of stromal-cell-derived factor 1.
7 or ligands, such as CCR5-Delta32, CCR2-V64I, stromal cell-derived factor-1 3'alpha, and CCR5 promoter
8 ested the hypothesis that blockade of SDF-1 (stromal cell-derived factor 1), a key stem cell mobilize
9 n CXCR4, which binds the chemokine CXCL12 or stromal cell-derived factor-1, a chemokine that has been
11 block CXCR4 usage and partially blocked with stromal cell-derived factor 1, all of which had no effec
12 The chemokine receptor CXCR4 and its ligand, stromal cell derived factor-1 alpha (SDF1 alpha) regulat
13 on 1 (PLCepsilon1) as a crucial regulator of stromal cell-derived factor 1 alpha (SDF-1alpha)-induced
15 hic factor (GDNF), sonic hedgehog (Shh), and stromal cell-derived factor 1 alpha (SDF1alpha), providi
16 y of CXCR4 antibodies to block chemotaxis to stromal cell-derived factor 1 alpha and to inhibit HIV-1
17 4) for the chemokine (C-X-C motif) ligand 12/stromal cell-derived factor-1 alpha (CXCL12/SDF-1 alpha)
18 ted by the chemokine (C-X-C motif) ligand 12/stromal cell-derived factor-1 alpha (CXCL12/SDF-1) via t
19 ross TNF-treated EC monolayers overlaid with stromal cell-derived factor-1 alpha (SDF-1 alpha) and su
21 ence stimulates proliferation, survival, and stromal cell-derived factor-1 alpha (SDF-1 alpha)-induce
22 ed chemotactically to their cognate ligands, stromal cell-derived factor-1 alpha and secondary lympho
24 sustained delivery of a synthetic analog of stromal cell-derived factor 1-alpha (engineered stromal
26 orphism in the 3' untranslated region of the stromal cell-derived factor 1 (also called pre-B-cell-st
27 to activate fibrocytes, probably by inducing stromal cell-derived factor-1 (also termed CXCL12), one
29 or CXCR4 to induce chemotaxis in response to stromal cell derived factor 1 and abolished the activati
30 that interactions between the CXC chemokine stromal cell-derived factor 1 and its receptor CXC chemo
31 ith significantly upregulated mRNA levels of stromal cell-derived factor 1 and platelet-derived growt
32 many T lymphocytes migrate away than towards stromal cell-derived factor 1 and their directional migr
33 t to be involved in hemopoietic cell homing, stromal cell-derived factor-1 and its receptor CXC chemo
34 imals have increased chemotactic response to stromal cell-derived factor-1 and macrophage-inflammator
36 fibroblasts to secrete much higher levels of stromal-cell-derived factor 1 and vascular endothelial g
37 oid synoviocyte line, including a chemokine, stromal cell-derived factor 1, and several genes capable
38 scular endothelial growth factor-A [VEGF-A], stromal cell-derived factor-1, and matrix metalloproteas
39 in response to the chemokines MIP-3beta and stromal cell-derived factor-1; and 3) significantly incr
41 Chemokines such as CXCL12, previously called stromal cell-derived factor 1, are known to activate cel
43 otaxis toward the lymphoid tissue chemokines stromal cell-derived factor-1, B lymphocyte chemoattract
44 n expressions of mitochondrial cytochrome c, stromal cell-derived factor-1, C-X-C chemokine receptor
45 cent staining showed higher numbers of CD31+ stromal cell-derived factor-1+, chemokine receptor type
46 cell subsets revealed that migration toward stromal cell-derived factor 1/CXC ligand 12 (SDF-1/CXCL1
47 is usually stimulated by chemokines such as stromal cell-derived factor-1 (CXCL12) acting via G prot
48 ed that GC T cells would actively migrate to stromal cell-derived factor-1 (CXCL12), the CXCR4 ligand
49 condary lymphoid tissue chemokine, CCL21, or stromal cell-derived factor 1, CXCL12, which chemoattrac
50 sed CXCR4-mediated chemotaxis in response to stromal cell-derived factor 1/CXCL12 and abolished the p
52 e chemokine (SLC)/CC ligand (CCL)21), CXCR4 (stromal cell-derived factor-1/CXCL12), and CXCR5 (B cell
53 hypoxic preconditioning are mediated by the stromal cell-derived factor 1/CXCR4 axis, and that thera
55 hematopoietic compartment is associated with stromal cell-derived factor 1/CXCR4-dependent vasculogen
56 cally augmented along with downregulation of stromal cell-derived factor-1-degrading enzyme dipeptidy
57 eased vascular endothelial growth factor and stromal cell-derived factor 1 expression in fibroblasts;
58 s provided suggesting that downregulation of stromal cell-derived factor 1 expression in the bone mar
59 T cell expressed and secreted) (for HIVBaL), stromal cell-derived factor-1 (for HIVIIIB), or azidothy
60 ibility to T-tropic HIV-1; and (v) a ligand (stromal cell-derived factor 1) for or a monoclonal antib
61 ced molecule 1 ligand chemokine) and CXCL12 (stromal cell-derived factor 1) have not been established
63 inting to the potential role of a chemokine (stromal cell-derived factor 1) in lymphomagenesis, and s
64 d CXCR4 (specific receptor for CXC chemokine stromal cell-derived factor-1) in CLL cells of a patient
67 upernatants but no increase in the cytokines stromal cell-derived factor 1, macrophage inflammatory p
68 and RYR3 that occurred after treatment with stromal cell-derived factor 1, macrophage-inflammatory p
69 /or RYR2 mRNA was found after treatment with stromal cell-derived factor 1, macrophage-inflammatory p
70 ically associate and form a heterodimer upon stromal cell-derived factor-1 or CXCL12 (SDF-1) stimulat
72 (P = 0.04), stem cell factor (P = 0.05), and stromal cell-derived factor 1 (P = 0.03) compared to tho
73 nished hypoxia response, including decreased stromal cell-derived factor 1 (P<0.005) and vascular end
74 n-1 receptor 2, programmed cell death-1, and stromal cell-derived factor-1) pathways, as was histolog
75 rn to that of CD34(+) cells, and opposite to stromal cell-derived factor 1 plasma levels and correspo
76 ophic effects of mesenchymal stem cell (MSC) stromal cell-derived factor-1 release on the effects of
78 chemotactic activity comparable with that of stromal cell derived factor 1 (SDF-1), a highly efficaci
80 The C-X-C chemokine receptor type 4 (CXCR4)/stromal cell derived factor-1 (SDF-1 or CXCL12) interact
81 ne inactivation studies have shown that both stromal cell derived factor-1 (SDF-1) and chemokine rece
84 ypoxia-inducible factor-1alpha (HIF-1alpha), stromal cell derived factor-1 (SDF-1), matrix metallopro
86 cells express alpha-smooth muscle actin and stromal cell-derived factor 1 (SDF-1) and are tumorigeni
87 XCR4 is the receptor for the alpha-chemokine stromal cell-derived factor 1 (SDF-1) and has been shown
88 study was to analyze the role of a chemokine stromal cell-derived factor 1 (SDF-1) and its receptor C
89 bular joint (TMJ) and to explore the role of stromal cell-derived factor 1 (SDF-1) and regulated on a
90 ation-dependent chemotaxis to their ligands, stromal cell-derived factor 1 (SDF-1) and VCAM-1, which
92 ned for associations of previously described stromal cell-derived factor 1 (SDF-1) chemokine and CCR5
94 hibit significantly enhanced chemotaxis to a stromal cell-derived factor 1 (SDF-1) gradient and adher
95 the chemokine receptor CXCR4 by its agonist stromal cell-derived factor 1 (SDF-1) has been associate
96 wn that T cells move away from the chemokine stromal cell-derived factor 1 (SDF-1) in a concentration
99 ic chondrocytes, while its ligand, chemokine stromal cell-derived factor 1 (SDF-1) is expressed in th
102 scular endothelial growth factor (VEGF), and stromal cell-derived factor 1 (SDF-1) than cells from un
108 ndertaken to investigate the hypothesis that stromal cell-derived factor 1 (SDF-1), a CXC chemokine (
109 d murine MCP-1 and not to murine KC or human stromal cell-derived factor 1 (SDF-1), consistent with t
110 Therefore, we explored the possibility that stromal cell-derived factor 1 (SDF-1), the ligand for CX
112 opoietic progenitors, it (1) potentiates the stromal cell-derived factor 1 (SDF-1)-dependent chemotax
113 dly and dose-dependently inhibited basal and stromal cell-derived factor 1 (SDF-1)-induced BMC migrat
114 ween GPI+ and GPI(neg) NK cells and impaired stromal cell-derived factor 1 (SDF-1)-induced chemotaxis
117 tumor cells through their ability to secrete stromal cell-derived factor 1 (SDF-1); CAFs promote angi
118 ating evidence indicates that interaction of stromal cell-derived factor 1 (SDF-1/CXCL12 [CXC motif,
120 he hypothesis that chemokines in general and stromal cell-derived factor 1 (SDF-1; CXCL12) in particu
123 CD20 is directly upregulated by CXCR4 ligand stromal cell-derived factor 1 (SDF-1alpha, CXCL12) produ
126 ment, where evidence points to the chemokine stromal cell-derived factor-1 (SDF-1 or CXCL12; expresse
127 is a specific receptor for the CXC chemokine stromal cell-derived factor-1 (SDF-1) and a coreceptor f
128 n (chemotaxis) in response to the chemokines stromal cell-derived factor-1 (SDF-1) and B-lymphocyte c
129 ediates lymphocyte chemotaxis in response to stromal cell-derived factor-1 (SDF-1) and functions as a
132 the interaction between the HIF-1-dependent stromal cell-derived factor-1 (SDF-1) and its receptor,
133 ression of both the EPC mobilizing chemokine stromal cell-derived factor-1 (SDF-1) and of vascular ep
142 We recently found that the CXC-chemokine stromal cell-derived factor-1 (SDF-1) is a highly effica
150 Based on a short hairpin RNA library and stromal cell-derived factor-1 (SDF-1) migration screenin
151 towards a gradient of the chemotactic factor stromal cell-derived factor-1 (SDF-1) produced by stroma
154 tion of chemokines, the role of signaling by stromal cell-derived factor-1 (SDF-1) through its recept
155 ly and reversibly antagonizes the binding of stromal cell-derived factor-1 (SDF-1) to its receptor CX
158 higher plasma levels of the chemokine CXCL12/stromal cell-derived factor-1 (SDF-1) were achieved in a
160 eta-1, can strikingly stimulate secretion of stromal cell-derived factor-1 (SDF-1), also known as CXC
161 flammatory mediators, such as the chemokine, stromal cell-derived factor-1 (SDF-1), and factors that
162 FLSs constitutively expressed the chemokine stromal cell-derived factor-1 (SDF-1), and that pertussi
163 ets, the CXCR4 is the receptor for chemokine stromal cell-derived factor-1 (SDF-1), and the CCR4 is t
164 functional CXCR4 receptors for the chemokine stromal cell-derived factor-1 (SDF-1), as demonstrated b
165 ), a HIF-1alpha-independent up-regulation of stromal cell-derived factor-1 (SDF-1), as well as endoth
166 stology and immunohistochemical detection of stromal cell-derived factor-1 (SDF-1), beta-actin, vascu
167 compared with that of its only known ligand, stromal cell-derived factor-1 (SDF-1), by in situ hybrid
168 receptor 4 (CXCR4), the primary receptor for stromal cell-derived factor-1 (SDF-1), is involved in bo
169 Here, we show that its cognate chemokine, stromal cell-derived factor-1 (SDF-1), promotes the surv
172 endent cytokine transcription in response to stromal cell-derived factor-1 (SDF-1), the sole chemokin
174 stimulated immature B cells are defective in stromal cell-derived factor-1 (SDF-1)-induced calcium mo
175 al evaluation, 32 efficiently inhibits CXCR4/stromal cell-derived factor-1 (SDF-1)-mediated modulatio
177 r pathway may participate, together with the stromal cell-derived factor-1 (SDF-1)/C-X-C chemokine re
179 cells were found to upregulate production of stromal cell-derived factor-1 (SDF-1)/CXCL12 in human fi
180 ween the upregulation of the chemoattractant stromal cell-derived factor-1 (SDF-1)/CXCL12 in the inju
183 between the chemokine receptor 4 (CXCR4) and stromal cell-derived factor-1 (SDF-1, also known as CXCL
189 CXCR4 is a chemokine receptor that binds stromal cell-derived factor-1 (SDF-1; also known as CXCL
190 chemokine receptor 4 (CXCR4) and its ligand, stromal cell-derived factor-1 (SDF-1alpha or CXC chemoki
192 beta 1-integrin ligand fibronectin regulated stromal-cell derived factor-1 (SDF-1) activation of ERK.
193 ent evidence demonstrates that the chemokine stromal-cell derived factor-1 (SDF-1, also known as CXCL
194 molecule E-selectin and the chemoattractant stromal-cell-derived factor 1 (SDF-1) in discrete, disco
195 selective activation of chemokines, such as stromal-cell-derived factor 1 (SDF-1), macrophage inflam
198 C chemokine ligand 12 (CXCL12, also known as stromal cell-derived factor 1 [SDF-1]), a chemokine prev
200 R7 by their shared cognate chemokine ligand (stromal cell-derived factor-1 [SDF-1]) in Stx-mediated p
202 onstitutively expressed in the CNS (known as stromal cell-derived factor 1; SDF-1), regulates cleavag
203 afish has shown that the interaction between stromal cell-derived factor 1 (SDF1) and its G-protein-c
205 1-deficient MKs in response to a gradient of stromal cell-derived factor 1 (SDF1), a major chemokine
206 nly in muscles atrophying because of cancer: stromal cell-derived factor 1 (SDF1), adenylate cyclase
207 human intercrine reduced in hepatomas (hIRH)/stromal cell-derived factor 1 (SDF1-alpha)/pre-B-cell gr
212 e of adhesion molecules, CXC receptor 4, and stromal cell-derived factor-1 signaling pathway in the r
213 Recent progress has implicated CXCR4-SDF1 (stromal cell-derived factor 1) signaling in regulating n
215 <em>CXCL12</em>, which encodes a chemokine, stromal cell-derived factor 1, that is expressed in card
216 and increased renal expression of its ligand stromal cell-derived factor 1, thus favoring mobilizatio
217 ein 7, macrophage colony-stimulating factor, stromal cell-derived factor-1, tissue inhibitor of metal
218 r adhesion molecule 1; interleukin 6 [IL-6]; stromal cell-derived factor 1; tissue inhibitor of metal
219 , dose-dependent inhibitor of the binding of stromal cell-derived factor 1 to its receptor, CXCR4.
220 tor-alpha; chemokine (C-X-C motif) ligand 1; stromal cell-derived factor 1; transforming growth facto
221 ediated by E-selectin and can be enhanced by stromal cell-derived factor-1 under different wall shear
222 ue repair and suggest that overexpression of stromal cell-derived factor-1 via gene therapy is a stra
225 actors, transforming growth factor alpha and stromal cell-derived factor 1, was not affected by 100 p
227 roblast growth factor, stem cell factor, and stromal cell-derived factor-1, whereas SVPs release high
230 n-1 receptor 2, programmed cell death-1, and stromal cell-derived factor-1) with consequent myocardia
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。